Sumatriptan Succinate Tablets

SOL #: SPE2D223R0003Award Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Carole Park, AU-ACT, Australia

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Nov 21, 2022
2
Last Updated
Jul 3, 2025

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Modification SPE2D223D0009 P00002 posted to announce exercising of Option Year Two (2), effective July 25, 2025 through July 24, 2026.

People

Points of Contact

Nancy FernandezPRIMARY
Jason WraySECONDARY

Files

Files

Download
Download
Download
Download

Versions

Version 9Viewing
Award Notice
Posted: Jul 3, 2025
Version 8
Award Notice
Posted: May 16, 2024
View
Version 7
Award Notice
Posted: Aug 24, 2023
View
Version 6
Award Notice
Posted: Jul 25, 2023
View
Version 5
Solicitation
Posted: Feb 3, 2023
View
Version 4
Solicitation
Posted: Jan 4, 2023
View
Version 3
Solicitation
Posted: Dec 15, 2022
View
Version 2
Solicitation
Posted: Dec 14, 2022
View
Version 1
Pre-Solicitation
Posted: Nov 21, 2022
View
Sumatriptan Succinate Tablets | GovScope